CONSOLIDATED BALANCE SHEETS (UNAUDITED) (EUR €) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Current Assets
Cash	€ 1,667	€ 297
Receivable other	305	3,712
Prepaid expenses	101	57
Total current assets	2,073	4,066
Property and equipment, net of accumulated depreciation of E274 at March 31, 2014 and E281 at December 31, 2013	114	117
In-process research and development	2,266	2,266
Goodwill	6,671	6,671
Total assets	11,124	13,120
Current Liabilities
Accounts payable	657	858
Acquisition-related contingent consideration	236	236
Current portion of convertible notes payable to related parties	38,227	39,123
Total current liabilities	39,120	40,217
Shareholders' Equity (Deficit)
Common stock, U.S. $0.01 par value; 850,000,000 shares authorized; issued 298,418,813 at March 31, 2014 and at December 31, 2013	2,491	2,491
Preferred stock, U.S. $0.01 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	33,904	33,876
Deficit accumulated during the development stage	(65,074)	(64,165)
Accumulated other comprehensive income	683	701
Total shareholders' equity (deficit)	(27,996)	(27,097)
Total liabilities and shareholders' equity (deficit)	€ 11,124	€ 13,120